CymitQuimica logo

CAS 138614-30-9

:

Icatibant acetate

Description:
Icatibant acetate is a synthetic peptide that functions as a selective bradykinin B2 receptor antagonist. It is primarily used in the treatment of hereditary angioedema, a condition characterized by recurrent episodes of severe swelling. The substance is known for its ability to inhibit the action of bradykinin, a peptide that promotes vasodilation and increases vascular permeability, thereby reducing the symptoms associated with angioedema. Icatibant acetate is administered via subcutaneous injection and is characterized by its relatively rapid onset of action. The compound is typically formulated as a sterile solution for injection and has a specific molecular structure that contributes to its pharmacological activity. Its safety profile has been established through clinical trials, and it is generally well-tolerated, although some patients may experience injection site reactions or other mild side effects. Overall, Icatibant acetate represents a significant advancement in the management of hereditary angioedema, providing patients with an effective therapeutic option.
Formula:C59H89N19O13S・xC2H4O2
InChI:InChI=1/C59H89N19O13S.C2H4O2/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66;1-2(3)4/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69);1H3,(H,3,4)/t33-,35+,37+,38?,39-,40-,41-,42-,43?,44?,45?,46?;/m0./s1
Synonyms:
  • Hoe 140
  • (R)-Arginyl-(S)-arginyl-(S)-prolyl-(2S,4R)-(4-hydroxyprolyl)glycyl-(S)-(3-(2-thienyl)alanyl)-(S)-seryl-(R)-((1,2,3,4-tetrahydro-3-isoquinolyl)carbonyl)-(2S,3aS,7aS)-((hexahydro-2-indolinyl)carbonyl)-(S)-arginine acetate (salt)
  • L-Arginine, D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2alpha,3abeta,7abeta)-octahydro-1H-indole-2-carbonyl-, acetate (salt)
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
  • Ref: IN-DA0018VS

    5mg
    99.00€
    10mg
    125.00€
    25mg
    149.00€
    50mg
    192.00€
    100mg
    229.00€
    250mg
    530.00€
  • Icatibant Acetate

    CAS:
    <p>Icatibant Acetate</p>
    Purity:≥98%
    Molecular weight:1364.57g/mol

    Ref: 54-BUP03567

    2mg
    149.00€
    5mg
    271.00€
    10mg
    424.00€
    25mg
    701.00€
    50mg
    982.00€
    100mg
    1,170.00€
  • Icatibant acetate

    CAS:
    Formula:C61H93N19O15S
    Purity:(HPLC) ≥ 95.0%
    Color and Shape:White to almost white powder
    Molecular weight:1364.57

    Ref: 7W-GK9272

    ne
    To inquire
  • Icatibant Acetate

    CAS:
    <p>Icatibant Acetate, an antagonist of the bradykinin B2 receptor, is used in the treatment of hereditary angioedema.</p>
    Formula:C61H93N19O15S
    Purity:99.68%
    Color and Shape:Solid
    Molecular weight:1364.57
  • Icatibant Acetate

    CAS:
    <p>Applications Icatibant Acetate is a bradykinin B2 receptor antagonist that has been recently approved for treatment of acute attacks of hereditary angioedema (HAE).<br>References Greve, J., et al.: Int. J. Dermatol., 50, 1294 (2011); Cole, S.W., et al.: Ann. Pharmacother., 47, 49 (2013)<br></p>
    Formula:C59H89N19O13S·x(C2H4O2)
    Color and Shape:Neat
    Molecular weight:1304.54 + x(60.05)

    Ref: TR-I163750

    1mg
    221.00€
    5mg
    624.00€
    25mg
    1,204.00€
  • Icatibant acetate

    CAS:
    <p>Icatibant is a 10 amino acid peptidomimetic of bradykinin and a selective antagonist to the bradykinin B2 receptor. Icabinant has been used for the treatment of attacks in patients with hereditary angioedema. Recent evidence has shown a link between dysregulated bradykinin‐mediated inflammation and acute respiratory distress syndrome (ARDS), a common complication in COVID-19 patients. Icatibant was proposed to inhibit excessive activation of the bradykinin B2 receptor during the SARS-CoV-2 infection, reducing the risk of ARDS.</p>
    Formula:C59H89N19O13S•(C2H4O2)x
    Purity:Min. 98 Area-%
    Color and Shape:Powder
    Molecular weight:1,304.52 g/mol

    Ref: 3D-FI146277

    10mg
    266.00€
    25mg
    500.00€
    50mg
    711.00€
    100mg
    1,034.00€
    250mg
    1,248.00€